News
New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed ...
Symptoms of inflammatory bowel disease (IBD) range from diarrhea and abdominal pain to nausea, fever, loss of appetite, fatigue and, at times, rectal bleeding. No single test can confirm IBD, which ...
Close collaboration between researchers and clinicians at Mayo is what makes the steps of translation — from discovery to the ...
The clinical trial studied the safety of the treatment on all seven patients and tracked its effectiveness on six. The patients were monitored for two years after receiving the transplants.
A French government working group recommended a sweeping plan to publicize study data and issue guidelines for reporting ...
15d
News-Medical.Net on MSNClinical trial underway to assess effectiveness and safety of potential Long Covid treatmentA clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca's long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential ...
Careful examination of clinical trial data and a better understanding of risk factors can help rheumatologists determine if a ...
Veru Inc. updates on its Phase 2b clinical trials, expecting safety data and discussing plans for Phase 3 with the FDA. Veru Inc. reported its financial results for the second quarter of fiscal ...
and its safety continues to be closely monitored,” the authors wrote. The differences between trials in glucocorticoid dosing and reported safety outcomes was a major limitation. The phase 2 ...
4d
News-Medical.Net on MSNTirzepatide outperforms semaglutide in weight loss clinical trialTirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...
9d
Sportschosun on MSNHKINOEN GLP1 series once-weekly obesity treatment approved by the Ministry of Food and Drug Safety for phase 3 clinical trials in KoreaAs the obese population increases worldwide, the development of obesity treatments is also becoming more active. The global ...
ATH-1105 is the Company's novel, orally available, brain-penetrant, next-generation small molecule drug candidate designed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results